Inhibiting the PI3K/AKT-PFKFB3 signaling cascade effectively blocks glycolysis and significantly reduces the expression of fibrosis markers such as FN and α-SMA, thus delaying pulmonary fibrosis progression (Li Y. et al., 2025). Here, PIK3CG is linked to pulmonary fibrosis.